title: 18 years mitotane therapy for intractable Cushing's disease.
authors.forename: S
authors.initials: S
authors.lastname: Kawai
authors.forename: Y
authors.initials: Y
authors.lastname: Ichikawa
authors.forename: J
authors.initials: J
authors.lastname: Kaburaki
authors.forename: T
authors.initials: T
authors.lastname: Yoshida
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage* / Q000009:adverse effects; D003480:Cushing Syndrome / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008134:Long-Term Care; D008939:Mitotane / Q000008:administration & dosage* / Q000009:adverse effects; D009384:Paraneoplastic Endocrine Syndromes / Q000188:drug therapy*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D008939:Mitotane